CHKP
Check Point Software Technologies Ltd.
CHKP has lower modeled downside risk, despite its lower overall score.
SNDK
Sandisk Corporation
SNDK has the edge over CHKP overall, supported by stronger fundamentals and stronger modeled upside.
CHKP Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| Strong | |
| Stable |
CHKP's profitability and cash flow are currently strong, and its revenue and balance sheet are stable.
SNDK Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
SNDK's revenue, profitability, cash flow and balance sheet are all currently strong.
CHKP PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 14x | $147 | — |
| Current | 15x | $147 | — |
| Cheap | 19x | $187 | +26% |
| Fair | 21x | $203 | +38% |
| Expensive | 25x | $241 | +64% |
Historical ranges are pointers, not guarantees.
CHKP's PE is in its cheap range at 15x. If earnings grow as analysts expect, today's price would be 14x next year's earnings.
SNDK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 3.8x | $937 | — |
| Current | 7.5x | $937 | — |
| Cheap | 17x | $2,173 | +132% |
| Fair | 24x | $3,048 | +225% |
| Expensive | 59x | $7,452 | +695% |
Historical ranges are pointers, not guarantees.
SNDK has the edge over CHKP in the historical PE scenario, which offers more potential upside but is not a forecast.
CHKP Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Stable | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect CHKP's earnings to grow and its profitability to improve, with its revenue holding steady.
SNDK Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| High |
SNDK has the edge over CHKP on the outlook, with more favorable revenue expectations.
CHKP Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $10.74 | +10% |
| Q2 2026 | $9.73 | +27% |
| Q1 2026 | $9.70 | +28% |
| Q4 2025 | $9.60 | +29% |
| Q3 2025 | $9.13 | +25% |
| Q2 2025 | $7.68 | +6.1% |
| Q1 2025 | $7.58 | +5.4% |
| Q4 2024 | $7.47 | +5.1% |
| Q3 2024 | $7.32 | +2.2% |
CHKP's earnings per share have climbed steadily: $9.73 over the past year, up 27% from the year before, and higher year over year for 16 quarters in a row.
SNDK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $247.30 | +97% |
| Q3 2026 | $125.61 | +$137.63 |
| Q2 2026 | $73.76 | +$85.07 |
| Q2 2025 | -$11.31 | -$6.65 |
SNDK has the edge over CHKP in the latest year-over-year earnings comparison.
CHKP Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $673.6M | +1.3% |
| Q1 2026 | $668.4M | +4.8% |
| Q4 2025 | $744.9M | +5.9% |
| Q3 2025 | $677.5M | +6.7% |
| Q2 2025 | $665.2M | +6% |
| Q1 2025 | $637.8M | +6.5% |
| Q4 2024 | $703.7M | +6.1% |
| Q3 2024 | $635.1M | +6.5% |
CHKP's revenue has grown year over year every quarter since late 2020: $674M last quarter, up 1.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 27% | -3.1 points |
| Q1 2026 | 28% | -3 points |
| Q4 2025 | 31% | -4.9 points |
| Q3 2025 | 29% | -5 points |
| Q2 2025 | 31% | -2.8 points |
| Q1 2025 | 31% | -1.7 points |
| Q4 2024 | 36% | -1.8 points |
| Q3 2024 | 34% | -3.5 points |
CHKP's operating margin was 27% last quarter, down 3.1 points from the same quarter a year ago, near the bottom of its range since 2019.
SNDK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11B | +378% |
| Q2 2026 | $9B | +372% |
| Q1 2026 | $6B | +251% |
| Q4 2025 | $3B | +61% |
| Q3 2025 | $2.3B | +23% |
| Q2 2025 | $1.9B | +8% |
| Q1 2025 | $1.7B | -0.6% |
| Q4 2024 | $1.9B | +13% |
SNDK's revenue has grown year over year for six quarters in a row: $11B last quarter, up 378% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 80% | +72 points |
| Q2 2026 | 78% | +78 points |
| Q1 2026 | 69% | +180 points |
| Q4 2025 | 35% | +25 points |
| Q3 2025 | 7.6% | -9 points |
| Q2 2025 | 0.9% | N/A |
| Q1 2025 | -111% | -122 points |
| Q4 2024 | 10% | +6.6 points |
SNDK has the edge over CHKP on profitability, with a higher operating margin.
CHKP Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $160.7M | -37% |
| Q1 2026 | $435.9M | +5.4% |
| Q4 2025 | $277.3M | +17% |
| Q3 2025 | $265.1M | +8.6% |
| Q2 2025 | $256M | +32% |
| Q1 2025 | $413.7M | +17% |
| Q4 2024 | $236.1M | +0.8% |
| Q3 2024 | $244.1M | +13% |
CHKP's free cash flow has been positive every quarter for seven years: $1.1B over the past year, about the same as the year before.
SNDK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $6.3B | +1340% |
| Q2 2026 | $7.1B | +14355% |
| Q1 2026 | $3B | +$3B |
| Q3 2025 | $438M | +$636M |
| Q2 2025 | $49M | +$217M |
| Q1 2025 | -$18M | +$23M |
| Q3 2024 | -$198M | -$157M |
SNDK generated $17.4B in free cash flow over the past year, more than ten times what it generated the year before.
CHKP Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -2.5% | -2.6M shares |
| 1 year | -6.3% | -6.9M shares |
| 3 years | -13% | -15.7M shares |
| 5 years | -23% | -31.3M shares |
| Available history | -31% | -47.3M shares |
CHKP has the edge over SNDK on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $324.9M |
| Q1 2026 | $325M |
| Q4 2025 | $425M |
| Q3 2025 | $366.8M |
| Q2 2025 | $325M |
| Q1 2025 | $325M |
| Q4 2024 | $324.9M |
| Q3 2024 | $325M |
CHKP spent $1.4B buying back its own shares over the past year, up 11% from the year before.
SNDK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.6% | -1M shares |
| 1 year | +3.4% | +5M shares |
| 3 years | +6.9% | +10M shares |
SNDK has 154M diluted shares, up 3.4% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $5B |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
CHKP Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 1.5x | Healthy |
| Q1 2026 | 0.9x | Very low |
| Q4 2025 | 0.2x | Very low |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.6x | Net Cash |
| Q1 2025 | -0.4x | Net Cash |
| Q4 2024 | -0.5x | Net Cash |
| Q3 2024 | -0.5x | Net Cash |
CHKP's net debt is about 1.5 years of its operating earnings (EBITDA), after holding more cash than debt a year ago.
SNDK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.7x | Net Cash |
SNDK has the edge over CHKP on leverage, with a lower net debt burden relative to earnings.
CHKP Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.5 | Neutral |
| Stochastic | 62.8 | Neutral |
CHKP's weekly RSI is 55 (neutral) and its Stochastic is 63 (neutral).
SNDK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.2 | Neutral |
| Stochastic | 10.6 | Oversold |
SNDK's weekly RSI is 40 (neutral) and its Stochastic is 11 (oversold).
CHKP PE vs Technology Sector
| Metric | CHKP | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 28x | 46% below |
| PE % | 8 | 35 | 27 pts below |
CHKP is trading at 15x earnings, a 46% discount to the Technology sector's median of 28x.
SNDK PE vs Technology Sector
| Metric | SNDK | Sector median | Relative |
|---|---|---|---|
| PE | 7.5x | 28x | 73% below |
| PE % | 4 | 27 | 23 pts below |
SNDK has the edge over CHKP on valuation relative to its sector.
CHKP Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $142.4 | 3.6% above |
| 20 week MA | $136.6 | 8% above |
| 50 week MA | $147.6 | 0.1% below |
| 100 week MA | $177.1 | 17% below |
| 200 week MA | $164.5 | 10% below |
CHKP has stronger trend alignment. CHKP is above 2 of 5 weekly averages versus SNDK above 0 of 3.
SNDK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,317.5 | 29% below |
| 20 week MA | $1,465.4 | 36% below |
| 50 week MA | $1,119.6 | 16% below |
SNDK is in a downtrend: it's below all three of its weekly moving averages, and 16% below its 50-week average.
CHKP Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $111.8 | $134.8 | +21% |
| 2021 | $134.8 | $114.9 | -15% |
| 2022 | $114.9 | $127.0 | +11% |
| 2023 | $127.0 | $152.8 | +20% |
| 2024 | $152.8 | $187.9 | +23% |
| 2025 | $187.9 | $189.6 | +0.9% |
| 2026 YTD | $189.6 | $147.5 | -22% |
CHKP has finished higher in five of the last six years. It's down 22% so far in 2026.
SNDK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $50.4 | $250.1 | +396% |
| 2026 YTD | $250.1 | $937.5 | +275% |
SNDK has the edge over CHKP on returns for 2026, with the stronger performance.